Correlating programmed death ligand 1 (PD-L1) expression, mismatch repair deficiency, and outcomes across tumor types: implications for immunotherapy

The identification of biomarkers associated with response to therapeutic agents is central to optimizing patient outcomes. Expression of the immune checkpoint proteins PD-1/L1, and DNA mismatch repair deficiency (dMMR) status may be predictive response biomarkers for immunotherapies, but their overl...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seung Tae, Klempner, Samuel J., Park, Se Hoon, Park, Joon Oh, Park, Young Suk, Lim, Ho Yeong, Kang, Won Ki, Kim, Kyoung-Mee, Lee, Jeeyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652789/
https://www.ncbi.nlm.nih.gov/pubmed/29100397
http://dx.doi.org/10.18632/oncotarget.20492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652789/
https://www.ncbi.nlm.nih.gov/pubmed/29100397
http://dx.doi.org/10.18632/oncotarget.20492

Ejemplares similares